Literature DB >> 24625436

Left atrial resection for T4 lung cancer without cardiopulmonary bypass: technical aspects and outcomes.

Geraud Galvaing1, Marie M Tardy2, Lucie Cassagnes3, Valinkini Da Costa2, Jean Baptiste Chadeyras2, Adel Naamee2, Patrick Bailly2, Edith Filaire4, Bruno Pereira5, Marc Filaire6.   

Abstract

BACKGROUND: Extended resection for lung cancer may improve survival of selected patients. Left-atrial resection is infrequently performed and surgical techniques are rarely reported; thus, oncologic results and survival rates remain uncertain. Our study describes surgical techniques, postoperative outcomes, and oncologic results of patients who received a combined multimodality treatment.
METHODS: Between October 2004 and March 2012 in our institution, 19 patients underwent extended lung resection involving the left atrium without cardiopulmonary bypass. We reviewed perioperative treatments, surgical procedures, and postoperative morbidity, mortality, and long-term survival rates.
RESULTS: Sixteen patients (68.4%) underwent neoadjuvant treatment including chemotherapy or radiotherapy. Eighteen pneumonectomies (94.7%) were performed, of which 12 (63.1%) were right sided. Dissection of the interatrial septum was complete in 4 patients (33.3%). Complete resection was achieved in 17 patients (89.4%) and 2 other patients (10.5%) were considered R1. The T-status was pT4 in all patients. Overall postoperative morbidity was 52.6%. The 30-day mortality rate was 10.5% and the 90-day mortality rate was 15.7%. Fifteen patients (93.7%) underwent adjuvant treatment. The mean follow-up time was 32.5 months. The 5-year probability of survival was 43.7%. Three patients (15.7%) were alive at greater than 6 years postsurgery.
CONCLUSIONS: Extended lung surgery with partial resection of the left atrium is a feasible procedure with acceptable morbidity. An interatrial septum dissection, by increasing the length of the atrial cuff, allows complete resection. Long-term survival can be achieved in highly selected patients who have undergone multimodal therapy.
Copyright © 2014 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24625436     DOI: 10.1016/j.athoracsur.2013.12.086

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  8 in total

1.  Initial extended resection or neoadjuvant therapy for T4 non-small cell lung cancer-What is the evidence?

Authors:  Ilkka Ilonen; David R Jones
Journal:  Shanghai Chest       Date:  2018-10-11

Review 2.  Extended resections of non-small cell lung cancers invading the aorta, pulmonary artery, left atrium, or esophagus: can they be justified?

Authors:  Emily S Reardon; David S Schrump
Journal:  Thorac Surg Clin       Date:  2014-09-11       Impact factor: 1.750

Review 3.  Surgery for malignant lesions of the chest which extensively involved the mediastinum, lung, and heart.

Authors:  Yugo Tanaka; Daisuke Hokka; Hiroyuki Ogawa; Nahoko Shimizu; Takeshi Inoue; Hiroshi Tanaka; Yutaka Okita; Yoshimasa Maniwa
Journal:  Gen Thorac Cardiovasc Surg       Date:  2017-05-24

Review 4.  Atrial resection for T4 non-small cell lung cancer with left atrium involvement: a systematic review and meta-analysis of survival.

Authors:  Shadi Hamouri; Nasr Alrabadi; Sebawe Syaj; Hassan Abushukair; Obada Ababneh; Leen Al-Kraimeen; Majd Al-Sous; Erich Hecker
Journal:  Surg Today       Date:  2022-01-09       Impact factor: 2.549

Review 5.  Surgery for lung cancer invading the mediastinum.

Authors:  Adnan M Al-Ayoubi; Raja M Flores
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

6.  Surgical outcome of patients with lung cancer involving the left atrium.

Authors:  Takuma Tsukioka; Makoto Takahama; Ryu Nakajima; Michitaka Kimura; Hidetoshi Inoue; Ryoji Yamamoto
Journal:  Int J Clin Oncol       Date:  2016-06-04       Impact factor: 3.402

7.  [Surgical Procedures and Perioperative Management for Non-small Cell Lung Cancer Complicated with Left Atrial Tumor Thrombus].

Authors:  Tong Bao; Fei Xiao; Deruo Liu; Yongqing Guo; Chaoyang Liang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2018-01-20

Review 8.  Extended pneumonectomy for advanced lung cancer with cardiovascular structural invasions.

Authors:  Shi-Min Yuan
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2018-04-30       Impact factor: 0.332

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.